This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.
Key Takeaways
Adults with PTSD have approximately 30 to 50% higher risk of developing type 2 diabetes compared with adults without PTSD.
Veterans with PTSD have particularly elevated rates, partly from PTSD itself and partly from medication and lifestyle pathways.
Chronic cortisol elevation, sleep disruption, inflammatory pathways, and disordered eating all contribute to the PTSD-diabetes link.
Trauma-focused therapies (CPT, PE, EMDR) have established efficacy and improve both PTSD symptoms and downstream behaviors.
Some PTSD medications (atypical antipsychotics, certain antidepressants) can affect weight and glucose; choice matters in diabetes.
Post-traumatic stress disorder has a meaningful but underrecognized relationship with type 2 diabetes. Adults with PTSD have approximately 30 to 50% higher risk of developing type 2 diabetes compared with adults without PTSD — an effect independent of depression, which often coexists with PTSD. The relationship is driven by biological mechanisms (chronic cortisol elevation, inflammation, autonomic nervous system dysregulation, HPA axis disruption) and behavioral pathways (sleep disruption, disordered eating, reduced physical activity, substance use). Once both conditions are present, self-management is uniquely challenging because PTSD symptoms (avoidance, hyperarousal, intrusive memories) interfere with the consistent attention that diabetes care requires. Veterans represent a particularly affected population. This guide covers the scope of the problem, the mechanisms, and the evidence-based treatments that address both conditions.
Some psychiatric medications used commonly (quetiapine off-label for sleep, atypical antipsychotic augmentation) worsen metabolic risk.
The VA system has dedicated diabetes prevention and management programs for veterans with PTSD.
Service-connected disability ratings for diabetes are available for veterans with documented exposure (Agent Orange) and metabolic syndrome relationships.
Evidence-Based Trauma-Focused Therapies
Therapy
Description
Sessions
Evidence
Cognitive Processing Therapy (CPT)
Cognitive restructuring of trauma-related thoughts
12 sessions
Established for combat, sexual assault PTSD
Prolonged Exposure (PE)
Gradual exposure to trauma memories and avoided situations
8-15 sessions
Established; large effect sizes
EMDR
Eye movement desensitization and reprocessing
6-12 sessions
Established; works well for single-incident trauma
Treatment plans need to address coexisting conditions.
When to Seek Professional Help
Recurrent intrusive memories, nightmares, or flashbacks of traumatic events.
Persistent avoidance of trauma-related situations or thoughts.
Hyperarousal, hypervigilance, easily startled.
Negative mood and cognition changes after trauma.
Symptoms persist 1+ month after the event.
VA system for veterans (vha.gov) has dedicated PTSD programs.
National Center for PTSD (ptsd.va.gov) has clinician directories.
Crisis support: 988 Suicide and Crisis Lifeline; Veterans Crisis Line at 988 then press 1.
The Bottom Line
PTSD increases type 2 diabetes risk by approximately 30 to 50% through both biological mechanisms (HPA axis dysregulation, inflammation, autonomic dysregulation, sleep disruption) and behavioral pathways (avoidance of medical care, disordered eating, substance use, reduced exercise). The effect is independent of depression, which often coexists. Veterans with PTSD have particularly elevated rates — 50 to 80% higher diabetes risk — driven by combat exposure, post-deployment lifestyle changes, and metabolic effects of common psychiatric medications. Three evidence-based trauma-focused therapies are first-line treatment: Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and EMDR. All have established efficacy in randomized trials. Pharmacotherapy: sertraline and paroxetine are FDA-approved for PTSD; prazosin treats trauma nightmares with minimal glucose effects; quetiapine and other atypical antipsychotics carry substantial metabolic risk and need careful consideration. CGMs help maintain glucose monitoring during avoidance periods. Treating PTSD effectively often improves diabetes outcomes substantially through better sleep, reduced cortisol, and reduced behavioral avoidance. The VA system has dedicated programs for veterans. Crisis support is available 24/7 through 988 (Veterans Crisis Line: 988 then press 1). See our broader anxiety and diabetes guide for related context.
Frequently Asked Questions
Does PTSD increase diabetes risk?
Yes, by approximately 30 to 50%. The Roberts JAMA Psychiatry study found women with PTSD had a 49% higher risk of developing type 2 diabetes over the follow-up period. Similar effects appear in veterans and other adult populations. The mechanisms are biological (chronic cortisol elevation, inflammation, autonomic dysregulation) and behavioral (sleep disruption, disordered eating, reduced exercise, substance use). The effect is independent of depression, which often coexists with PTSD.
Why are veterans at particularly elevated risk?
Veterans with PTSD have multiple risk pathways: combat exposure produces severe PTSD, military service contributes to specific traumatic experiences, and the medications used to treat PTSD (atypical antipsychotics like quetiapine, certain antidepressants) carry metabolic risks. Additionally, post-deployment lifestyle changes — reduced exercise, dietary shifts, sleep disruption — compound the biological PTSD pathway. The VA system has dedicated programs addressing this overlap.
What therapies treat PTSD effectively?
Three evidence-based trauma-focused therapies are first-line: Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and Eye Movement Desensitization and Reprocessing (EMDR). All three have established efficacy in randomized controlled trials. Trauma-focused therapy has effect sizes comparable to or larger than medication. For PTSD with comorbid diabetes, successful treatment often improves self-management indirectly through better sleep, reduced cortisol, and reduced avoidance of medical care.
Which medications are best for PTSD with diabetes?
Sertraline and paroxetine are FDA-approved for PTSD; both are SSRIs with relatively favorable metabolic profiles. Venlafaxine (SNRI) is also commonly used. Prazosin is helpful for trauma nightmares with minimal glucose effects. Atypical antipsychotics (especially quetiapine) are sometimes used adjunctively but carry weight gain and glucose dysregulation risks — see our antipsychotics-and-diabetes article. Benzodiazepines are generally avoided in PTSD; they can mask hypoglycemia awareness in diabetes.
Sources
American Diabetes Association. Standards of Care in Diabetes 2024, Section 5 Facilitating Behavior Change. Diabetes Care 47(Suppl 1).
Roberts AL, et al. Posttraumatic stress disorder and incidence of type 2 diabetes mellitus. JAMA Psychiatry.
Vaccarino V, et al. PTSD and metabolic syndrome — meta-analysis. Psychosomatic Medicine.
How SSRIs affect glucose in people with diabetes — small acute effects, gradual weight gain over years, and the brand-by-brand differences that matter.
How antipsychotics affect diabetes risk — olanzapine and clozapine are the highest risk, aripiprazole and lurasidone the lowest, plus the metformin offset.